Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Frechen

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|September 19, 2024
Population pharmacokinetic-pharmacodynamic model of elinzanetant based on integrated clinical phase I and II dataStefan Willmann, Adam Lloyd, Rupert Austin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 22, 2011
Recommending early integration of palliative care - does it work?Jan Gaertner, Juergen Wolf, Sebastian Frechen, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 5, 2023
Applied physiologically-based pharmacokinetic modeling to assess uridine diphosphate-glucuronosyltransferase-mediated drug-drug interactions for VericiguatSebastian Frechen, Ibrahim Ince, André Dallmann, et al.
Clinical Pharmacokinetics|December 20, 2019
A Physiologically Based Pharmacokinetic Model of Voriconazole Integrating Time-Dependent Inhibition of CYP3A4, Genetic Polymorphisms of CYP2C19 and Predictions of Drug-Drug InteractionsXia Li, Sebastian Frechen, Daniel Moj, et al.
Journal of Clinical Pharmacology|June 29, 2021
Predictive Performance of Physiology-Based Pharmacokinetic Dose Estimates for Pediatric Trials: Evaluation With 10 Bayer Small-Molecule Compounds in ChildrenIbrahim Ince, André Dallmann, Sebastian Frechen, et al.
Journal of Clinical Pharmacology|May 20, 2020
A Novel Study Design Using Continuous Intravenous and Intraduodenal Infusions of Midazolam and Voriconazole for Mechanistic Quantitative Assessment of Hepatic and Intestinal CYP3A InhibitionXia Li, Lisa Junge, Max Taubert, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 22, 2023
Physiologically based pharmacokinetic modeling of tacrolimus for food-drug and CYP3A drug-drug-gene interaction predictionsHelena Leonie Hanae Loer, Denise Feick, Simeon Rüdesheim, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 11, 2023
Physiologically-based pharmacokinetic modeling of quinidine to establish a CYP3A4, P-gp, and CYP2D6 drug-drug-gene interaction networkDenise Feick, Simeon Rüdesheim, Fatima Zahra Marok, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 1, 2019
Open Systems Pharmacology Community-An Open Access, Open Source, Open Science Approach to Modeling and Simulation in Pharmaceutical SciencesJörg Lippert, Rolf Burghaus, Andrea Edginton, et al.
Clinical Pharmacology and Therapeutics|February 15, 2025
A Comprehensive CYP2D6 Drug-Drug-Gene Interaction Network for Application in Precision Dosing and Drug DevelopmentSimeon Rüdesheim, Helena Leonie Hanae Loer, Denise Feick, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
CPT: Pharmacometrics & Systems Pharmacology|September 19, 2024
Population pharmacokinetic-pharmacodynamic model of elinzanetant based on integrated clinical phase I and II dataStefan Willmann, Adam Lloyd, Rupert Austin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 22, 2011
Recommending early integration of palliative care - does it work?Jan Gaertner, Juergen Wolf, Sebastian Frechen, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 5, 2023
Applied physiologically-based pharmacokinetic modeling to assess uridine diphosphate-glucuronosyltransferase-mediated drug-drug interactions for VericiguatSebastian Frechen, Ibrahim Ince, André Dallmann, et al.
Clinical Pharmacokinetics|December 20, 2019
A Physiologically Based Pharmacokinetic Model of Voriconazole Integrating Time-Dependent Inhibition of CYP3A4, Genetic Polymorphisms of CYP2C19 and Predictions of Drug-Drug InteractionsXia Li, Sebastian Frechen, Daniel Moj, et al.
Journal of Clinical Pharmacology|June 29, 2021
Predictive Performance of Physiology-Based Pharmacokinetic Dose Estimates for Pediatric Trials: Evaluation With 10 Bayer Small-Molecule Compounds in ChildrenIbrahim Ince, André Dallmann, Sebastian Frechen, et al.
Journal of Clinical Pharmacology|May 20, 2020
A Novel Study Design Using Continuous Intravenous and Intraduodenal Infusions of Midazolam and Voriconazole for Mechanistic Quantitative Assessment of Hepatic and Intestinal CYP3A InhibitionXia Li, Lisa Junge, Max Taubert, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 22, 2023
Physiologically based pharmacokinetic modeling of tacrolimus for food-drug and CYP3A drug-drug-gene interaction predictionsHelena Leonie Hanae Loer, Denise Feick, Simeon Rüdesheim, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 11, 2023
Physiologically-based pharmacokinetic modeling of quinidine to establish a CYP3A4, P-gp, and CYP2D6 drug-drug-gene interaction networkDenise Feick, Simeon Rüdesheim, Fatima Zahra Marok, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 1, 2019
Open Systems Pharmacology Community-An Open Access, Open Source, Open Science Approach to Modeling and Simulation in Pharmaceutical SciencesJörg Lippert, Rolf Burghaus, Andrea Edginton, et al.
Clinical Pharmacology and Therapeutics|February 15, 2025
A Comprehensive CYP2D6 Drug-Drug-Gene Interaction Network for Application in Precision Dosing and Drug DevelopmentSimeon Rüdesheim, Helena Leonie Hanae Loer, Denise Feick, et al.
Pageof 5